Pre-Sterilized / Ready-to-Use Primary Packaging Market
Roots Analysis has
announced the addition of Pre-Sterilized
/ Ready-to-Use Primary Packaging Market report
to its list of offerings.
Presently, more than 150 pre-sterilized / RTU primary packaging systems,
including cartridges, syringes and vials, as well as their respective closure
systems are available worldwide. Majority (50%) of the pre-sterilized / RTU primary packaging systems are closures, followed by containers
(34%) and container-closure systems (16%). It is worth highlighting that, of
the total, 54 closures are suitable for use with vials, 19 are suitable for use
with syringes and the remaining 5 are compatible with cartridges.
To
request a sample copy / brochure of this report, please visit this – https://www.rootsanalysis.com/reports/224/request-sample.html
Amongst the primary packaging containers, vials and
syringes emerged as the most common types of pre-sterilized / RTU containers
manufactured by stakeholders engaged in this domain. This can be attributed to
the fact that these containers are the most suitable for packaging of small
volume of therapeutics, such as biologics, cell therapies, small molecules,
vaccines and other potent products.
Scope of the Report: -
The “Pre-Sterilized / Ready-to-Use
Primary Packaging: Focus on Cartridges, Syringes and Vials (2nd Edition) - Market
Distribution by Type of Packaging System (Vials, Syringes, Cartridges and
Closures), Packaging Material (Glass and Plastic) and Key Geography (North
America, Europe, Asia Pacific, Latin America, Middle East and North Africa and
Rest of the World) – Global Forecast 2021-2030” report features an
extensive study of the current market landscape and future potential of
ready-to-use primary packaging components, including cartridges, syringes and
vials, and their respective closure systems (such as stoppers, needle
shields and plungers) over the next decade. The study features an in-depth
analysis of the key drivers and trends related to this domain. Amongst other
elements, the report includes:
- A detailed
assessment of the current market landscape of ready-to-use primary
packaging components, featuring information on the type of
container (vials, syringes, cartridges and others), type of
fabrication material used (glass and plastic), sterilization
technique used (ethylene oxide sterilization, steam sterilization,
gamma irradiation, electron beam sterilization and dry heat
sterilization), volume of container (less than 50 ml, 50 ml to 100 ml
and more than 100 ml), compatible drug class (biologics and small
molecules) and type of closure (stoppers, plungers, tip caps /
needle shields, caps and seals). In addition, the chapter includes details
related to ready-to-use packaging system manufacturers, along with
information on their respective year of establishment, company size,
location of headquarters and key players (in terms of number of
offerings).
- A
competitiveness analysis of ready-to-use primary packaging system
manufacturers based on various relevant parameters, such as supplier
power (based on the experience / expertise of the
manufacturer) and key product specifications (type of container,
type of fabrication material used, type of closure, sterilization
technique used and compatible drug class).
- Elaborate
profiles of prominent players engaged in the development of ready-to-use
primary packaging systems. Each profile features a brief overview of the
company, details related to its financials (if available), product
portfolio, recent developments and an informed future outlook.
- An analysis of
the partnerships that have been inked by stakeholders engaged in this
domain, during the period 2015-2021, covering acquisitions, product /
technology integration agreements, supply agreements, product / technology
licensing agreements, product / technology development agreements, service
alliances, distribution agreements and other relevant types of deals.
- An insightful
discussion on the impact of the recent COVID-19 pandemic on the businesses
of primary pharmaceutical packaging manufacturers. In addition, we have
provided information on the strategic initiatives undertaken by
pharmaceutical players to mitigate the challenges affiliated with the
current global crisis.
- An in-depth
analysis to estimate the current and future demand for ready-to-use
container-closure systems based on various relevant parameters, such as
type of packaging system and type of fabrication material used, across
different regions, for the period 2021-2030.
- An elaborate
discussion on the key trends (such as the advent of personalized /
targeted therapies, shift towards more flexible packaging, rise of modular
manufacturing facilities and advancement in robotic packaging
solutions) that are likely to have an impact on the future adoption
of ready-to-use packaging systems. It also features a Harvey ball
analysis, highlighting the relative effect of each trend on the overall
pharmaceutical packaging industry.
- A case study on
the use of robotic machinery in pharmaceutical manufacturing and fill /
finish operations, highlighting the advantages of using automation /
automated technologies in such processes. Further, it presents the
profiles of industry players that provide such equipment for aseptic
processing of pharmaceuticals.
Key Questions Answered
- Who are the prominent players
engaged in the global pre-sterilized / ready-to-use primary packaging
market?
- What is the relative
competitiveness of different ready-to-use primary packaging system
manufacturers?
- Which partnership models are most
commonly adopted by stakeholders engaged in this industry?
- How is the recent COVID-19
pandemic likely to impact the global ready-to-use primary packaging
systems market?
- What is the current, global demand
for ready-to-use containers and closures?
- What are the major market trends
and driving factors that are likely to impact the growth of ready-to-use
primary packaging systems market?
- How is the current and future
opportunity likely to be distributed across key market segments?
To request a free insight to this report – https://www.rootsanalysis.com/reports/224/free-insights.html
Sterilization of primary packaging systems is considered
to be an essential step in the overall healthcare manufacturing process as it
deactivates various forms of contaminating agents (particularly referring to
bacteria, fungi, protozoa and viruses). Majority (43%) of the pre-sterilized /
RTU containers are sterilized using ethylene oxide, followed by those employing
steam sterilization (34%).
For
additional details, please visit - https://www.rootsanalysis.com/reports/view_document/pre-sterilized-ready-to-use-primary-packaging-market/224.html Or sales@rootsanalysis.com
Contact Details
Ben Johnson
+1 (415) 800 3415
ben.johnson@rootsanalysis.com
Roots Analysis
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis.com
Medium: https://medium.com/@RootsAnalysis
Pinterest: https://in.pinterest.com/RootsanalysisPin/_saved/
Comments
Post a Comment